IBM is set to release its earnings report on Wednesday, July 22, entering the period after already tempering investor expectations.
Last week, the company disclosed that its revenue would likely total $17.2 billion, falling short of the $17.86 billion analysts had forecasted. Earnings per share (EPS) estimates were also lowered to $2.93 from an expected $3.02.
This early warning triggered a selloff in its shares, suggesting much of the downside risk may now be priced in before the full earnings release.
Yet, the situation remains complex. IBM cited challenges such as ongoing memory shortages and the intense industry focus on artificial intelligence (AI), factors that are currently inhibiting its growth.
Despite these headwinds, Wall Street sentiment retains a cautiously optimistic tone. Recent analyst reports are predominantly bullish: among them, four 'Hold,' one 'Sell' from HSBC’s Stephen Bersey with a lowered price target from $231 to $191, and five 'Buy' recommendations.
JPMorgan’s Brian Essex updated his outlook on July 17 shortly after IBM’s preview, maintaining a 'Buy' rating even with a price target drop from $291 to $250. This reflects a reduced upside of 17.37% compared to the previous 36.52%, illustrating tempered but still positive confidence.
The aggregated view on Wall Street labels IBM as a 'Moderate Buy,' with the average 12-month price target near $295.76, implying a potential rally of about 39% according to TipRanks data from July 21.
Investors should note that nearly all non-positive adjustments to IBM’s outlook arrived within the past week, underscoring elevated uncertainty and the need for cautious positioning.
This material is informational and not a financial recommendation.